Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria.
Bolade Folasade Dele-OjoAdedapo AdesokanJoseph Olusesan FadarePaul Oladapo AjayiTaiwo Hussean RaimiSamuel Ayokunle DadaOjo Owolabi DeleJames Ayodele OgunmodedeTope Michael IpinimoOlumuyiwa Elijah AriyoBrian B GodmanPublished in: Current medical research and opinion (2024)
This study found that self-reported adverse effects of the Oxford/AstraZeneca COVID-19 vaccine were mild and short in duration. This outcome has promising implications for improving COVID-19 vaccine uptake in the immediate environment and Nigeria.